Announcements Trials
Browse Landscape

Phase

Phase 1 3

Status

Completed 3

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other solid neoplasm 3

Conditions

Breast Neoplasms 20Neoplasms 6Neoplasm Metastasis 3Advanced Malignant Solid Tumors 3Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Inflammatory Breast Neoplasms 1HER2+ Metastatic Breast Cancer (MBC) 1HER2 Positive Breast Carcinoma 1

Interventions

neratinib 3dacomitinib 1Vinorelbine 1TAK-243 1Paclitaxel 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Has results × Advanced Malignant Solid Tumors × neratinib × Clear all
NCT01128842 2018-12-19

A Study Of Neratinib (HKI-272) And Capecitabine In Japanese With Solid Tumor

Puma Biotechnology, Inc.

Phase 1 Completed
7 enrolled 13 charts
Other solid neoplasm

Advanced Malignant Solid Tumors

NCT00768469 2018-11-19

Study Evaluating Safety And Tolerability, Solid Tumor

Puma Biotechnology, Inc.

Phase 1 Completed
10 enrolled 11 charts
Other solid neoplasm

Advanced Malignant Solid Tumors

NCT00958724 2018-06-28

Study Evaluating Neratinib In Combination With Vinorelbine In Subjects With Advanced Or Metastatic Solid Tumors

Puma Biotechnology, Inc.

Phase 1 Completed
6 enrolled 13 charts
Other solid neoplasm

Advanced Malignant Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡